Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models
2007
Trastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function?
2013
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Contemporary Breast Radiotherapy and Cardiac Toxicity
2015
Cardiac side-effects of cancer chemotherapy
2010
Repair and Recombination: How to make ends meet
1995 StandoutNobel
Breast cancer
2016 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Cancer Treatment–Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities
2014
A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1
1999 Standout
MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER
1988
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
2007
Chemotherapy-Induced Cardiotoxicity: Detection, Prevention, and Management
2014
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
2010
The REDCap consortium: Building an international community of software platform partners
2019 Standout
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
2001
1998–1999 Patterns of Care Study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of Stage I-II breast cancer
2005
Measuring the quality of life of cancer patients: Psychometric properties of instruments
1988
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background
2013
Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab
2011
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
2012
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
2012
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Role of anthracyclines in the era of targeted therapy
2007
Transforming growth factor-beta activation in irradiated murine mammary gland.
1994
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
2009
Fluoroscopically Guided Interventional Procedures: A Review of Radiation Effects on Patients’ Skin and Hair
2010
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The validity of the Hospital Anxiety and Depression Scale
2002 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Redox-mediated activation of latent transforming growth factor-beta 1.
1996
The Role of Biologically Effective Dose (BED) in Clinical Oncology
2001
Cardiac Exposures in Breast Cancer Radiotherapy: 1950s–1990s
2007
Clonal selection and learning in the antibody system
1996 StandoutNature
Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy
2014
Transforming Growth Factor β in Tissue Fibrosis
1994 Standout
Cardiovascular effects of systemic cancer treatment
2010
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
2007
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
2009
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
A feasibility study to evaluate breast cancer patients’ knowledge of their diagnosis and treatment
2012
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
2015
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
2015
Cancer of the Ovary
2004 Standout
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
2010
Cancer drugs and the heart: importance and management
2012
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
2011
Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications
2015 StandoutNobel
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
Multiplexed cytokine detection on plasmonic gold substrates with enhanced near-infrared fluorescence
2012
Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response
2012
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
2010
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels.
2002
Breast Cancer Treatment
2019 Standout
Phase II Trial of Weekly Vinorelbine and Trastuzumab as First-Line Therapy in Patients with HER2+ Metastatic Breast Cancer
2002
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
2006
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
1992 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
2010
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Cannabinoids for Medical Use
2015 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Assessment of quality of life in clinical trials of cardiovascular therapies
1984
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results
1997 Standout
Cardiac toxicity in cancer survivors
2013
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Works of Peter Canney being referenced
Derivation and Application of Equations Describing the Effects of Fractionated Protracted Irradiation, Based on Multiple and Incomplete Repair Processes. Part I. Derivation of Equations
1993
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
2010
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
2009
Two Components of Repair in Irradiated Kidney Colony Forming Cells
1994
Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: A randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group
2006
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer
2009
A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea
1987
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)
2006
Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial
2007
Variation in the probability of cardiac complications with radiation technique in early breast cancer
2001
A phase II, multicentre, UK study of vinorelbine in advanced breast cancer
1994
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
2016
Carboplatin and 5-fluorouracil in advanced and recurrent squamous carcinoma of the head and neck
1993
Reducing cardiac dose in post-operative irradiation of breast cancer patients: the relative importance of patient positioning and CT scan planning.
1999
The prevalence of menopausal symptoms in patients treated for breast cancer
1994
Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy?
1990
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
1984